Prospeo
Hero Section BackgroundHero Section Background
SeaBeLife Biotech

SeaBeLife Biotech Email Formats

Biotechnology ResearchFlag of FRRoscoff, Brittany, France11-20 Employees

SeaBeLife Biotech Email Formats

SeaBeLife Biotech uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@seabelife.com), used 71.4% of the time.

FormatExamplePercentage
{first name}.{last name}
john.doe@seabelife.com
71.4%
{first initial}.{last name}
j.doe@seabelife.com
28.6%

Key Contact at SeaBeLife Biotech

Flag of FR

Romain Lucas

Head Of Chemistry - Cmc Director

Company overview

HeadquartersRoscoff, Brittany, France
Phone number+33298292348
Website
NAICS541714
Keywords
Paracetamol, Ferroptose, Insuffisance Hépatique Aiguë, Insuffisance Rénale Aiguë, Intoxication Médicamenteuse, Nécroptose, Nécrose Régulée, Hépatotoxicité, Maladies Neurodégénératives, Néphrotoxicité, Cisplatine
Founded2019
Employees11-20
Socials

About SeaBeLife Biotech

We develop small molecules that inhibit regulated necrosis using an original mechanism of action. Regulated necrosis is one of the recently identified pathophysiological factors in many diseases with severe outcomes. The technical, therapeutic and economic potential is major. Our activity focuses on the development of drugs inhibiting regulated necrosis, from the selection of the molecule to the proof of efficacy in the patient. We focus on acute and orphan diseases because preclinical and clinical development is facilitated, allowing proof of concept (POC) to be provided in humans more quickly. We have selected a lead molecule which is currently under preclinical development to treat acute kidney injury (AKI) induced by anti-cancer treatments (such as cisplatin) and to treat acute liver failure (ALF) induced by paracetamol poisoning. We have already identified molecules in our pipeline for which we obtained in cellulo POC in Neurodegenerative diseases and AMD.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry
Head
Manager

Employees by Department

SeaBeLife Biotech has 4 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore SeaBeLife Biotech's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2023-10-263$1,300,000
2024-05-229$1,600,000
2025-11-013$2,400,000

Funding Insights

$5,300,000

Total funding amount

$2,400,000

Most recent funding amount

3

Number of funding rounds

SeaBeLife Biotech Tech Stack

Discover the technologies and tools that power SeaBeLife Biotech's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

reCAPTCHA

Security

GeneratePress GP Premium

GeneratePress GP Premium

WordPress plugins

Slick

Slick

JavaScript libraries

Swiper

Swiper

JavaScript libraries

jQuery UI

jQuery UI

JavaScript libraries

Google Maps

Google Maps

Maps

Elementor

Elementor

Page builders

jQuery Migrate

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

jQuery

JavaScript libraries

GeneratePress

GeneratePress

WordPress themes

Frequently asked questions

SeaBeLife Biotech is located in Roscoff, Brittany, FR.
You can reach SeaBeLife Biotech at +33298292348.
SeaBeLife Biotech was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.
SeaBeLife Biotech has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.
SeaBeLife Biotech has raised a total of $5,300,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles